Professor EmeritusStewart Einfeld

Professor Einfeld is a member of the following research teams:

BMRI
CDRP
Mental Health

Childhood developmental disorders research programs Childhood diseases of the brain affect over 3% of Australian children under 10 years of age. Without early intervention, these disorders can progress to more severely disabling conditions in adolescence and later life. Based on the latest discoveries and expertise of leading researchers at the BMRI, the Institute provides care to children suffering from Autism, Down Syndrome, Attention Deficit Hyperactivity Disorder and other disorders of the brain and mind.

Developmental Psychiatry The ability to understand emotion in others is essential for the healthy development of all people. It guides response and decision making to social cues (e.g. aggression) and enhances capacity to develop social bonds and to nurture. Abnormalities of emotion perception may contribute to psychiatric disorders associated with social problems such as autism, schizophrenia, fragile x syndrome, and psychopathy. There has been an enormous increase in community awareness of autism, and Professor Einfeld has played a substantial role in supporting scientifically based understanding of autism and other developmental disorders in childhood. Autism is the prototype disorder of social dysfunction. One of the key impairments is an inability to respond appropriately to social cues, and advances in social neuroscience have identified the neuropeptide oxytocin as playing a key role in social behavior. This ancient mammalian peptide enhances peer recognition, social approach, and bonding behavior across numerous species. This has led some to speculate its use for the treatment of psychiatric disorders characterised by social deficit. Professor Einfeld’s team investigate the effect of oxytocin administration on emotion recognition for young people with autism spectrum disorders. Oxytocin nasal spray may lead to a brief, safe, and effective intervention to remedy emotion recognition deficits. Improvements in core symptoms, particularly if addressed early in life, may result in better outcomes for children with autism.